Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,573.66
(
0.13%
)
US TECH 100
29,463.20
(
0.13%
)
Dow Jones
50,978.62
(
0.61%
)
Brent Oil
90.91
(
-1.38%
)
Bitcoin
73,917.72
(
0.51%
)
News Focus
News Focus
Post# of 257656
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123036
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 69750

Thursday, 02/12/2009 8:26:58 PM

Thursday, February 12, 2009 8:26:58 PM

Post# of 257656
INS-19 (Neupogen) and INS-20 (Neulasta) are included in the five or six biologics MRK says it will have in phase-3 by 2012, according to Reuters. This suggests MRK knew as early as last December that it would be acquiring INSM.

http://www.reuters.com/article/marketsNews/idINN1243354920090212


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today